The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2024 | Current and future approaches to risk stratification in multiple myeloma: using dynamic models
Irene Ghobrial, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses the benefits and limitations of current approaches to risk stratification in multiple myeloma (MM), mentioning the 20/2/20 criteria. Dr Ghobrial highlights that using dynamic models, which bring together genomic data and information on the immune environment, may allow for more accurate determination of a patient’s risk of progression. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
